MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-BR-26-0046203
Bequeath Pharmaceutical Private Limited
Bequeath Pharmaceutical Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.08 Lakh
▼ 27% YoY
Net profit · FY 2025
₹54,173
Net margin 13.3%
EBITDA · FY 2025
₹54,173
EBITDA margin 13.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Bequeath Pharmaceutical Private Limited
Data last updated:
Bequeath Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2021PTC390572. Its GSTIN is 10AAKCB3410E1ZI (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Suman Kumari and Santosh Chaudhary.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Surya Prakash 1179 – A GF Block – G – 1 Aya Nagar Extn Ph – 6, Delhi, India – 110047.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.08 Lakh, a decline of 27% compared to the previous year. For the same year it recorded a net profit of ₹54,173 (net margin 13.3%) and EBITDA of ₹54,173 (EBITDA margin 13.3%).
Bequeath Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0046203).
Company Details of Bequeath Pharmaceutical Private Limited
CIN U24304DL2021PTC390572
Registration Number 390572
Incorporation Date 29 November 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-BR-26-0046203
Key People
Suman Kumari Director Santosh Chaudhary Director Recognitions & Rankings of Bequeath Pharmaceutical
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Surya Prakash 1179 – A GF Block – G – 1 Aya Nagar Extn Ph – 6, Delhi, India – 110047
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Bequeath Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Bequeath Pharmaceutical Private Limited
The main business activity of Bequeath Pharmaceutical is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bequeath Pharmaceutical Private Limited FY 2025 filings available
Bequeath Pharmaceutical Private Limited reported revenue of ₹4.08 Lakh (down 27% YoY) for FY 2025.
Revenue · FY 2025
₹4.08 Lakh ▼ 27%
Net profit · FY 2025
₹54,173 margin 13.3%
EBITDA · FY 2025
₹54,173 margin 13.3%
Compounded Annual Growth Rate (CAGR) of Bequeath Pharmaceutical Private Limited
Revenue CAGR growth
1 year
▼ 27%
EBITDA CAGR growth
1 year
▲ 254%
3 years · compounded
▲ 58%
Revenue fell 27% in the latest year. EBITDA rose 254% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Bequeath Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹54,173 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹54,173 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Bequeath Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 13.3% | •••• | •••• | •••• |
| Net Profit Margin | 13.3% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bequeath Pharmaceutical are in the company report.
Premium access
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Bequeath Pharmaceutical Private Limited
Bequeath Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Kumari | Director | 29 Nov 2021 | 4 Years 10 Months | Current |
| Santosh Chaudhary | Director | 29 Jul 2025 | 1 Years 2 Months | Current |
Peer Comparison of Bequeath Pharmaceutical Private Limited
Bequeath Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Manufacture of chemicals and chemical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Reval Paints Private Limited | ₹4.24 Lakh (FY 2025) | •••• | •••• | 1199.0% | •••• | Pune, Maharashtra, India |
| Medlong Life Sciences Private Limited | ₹4.2 Lakh (FY 2025) | •••• | •••• | •••• | Ramachandrapuram, Telangana, India | |
| Ohc Innovations Private Limited | ₹4.17 Lakh (FY 2025) | •••• | •••• | 3687.0% | •••• | Paonta Sahib, Himachal Pradesh, India |
| Twist Industries Private Limited | ₹4.16 Lakh (FY 2024) | •••• | •••• | •••• | Delhi, India | |
| Gydan Life Science Private Limited | ₹4.09 Lakh (FY 2025) | •••• | •••• | -92.0% | •••• | Rajarajeshwari Nagar, Karnataka, India |
| Bequeath Pharmaceutical Private Limited this company | ₹4.08 Lakh (FY 2025) | •••• | •••• | -27.0% | •••• | Delhi, India |
| Ardent Services Private Limited | ₹3.98 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | Mumbai, Maharashtra, India |
| Keladi Industries Private Limited | ₹3.88 Lakh (FY 2025) | •••• | •••• | 454.0% | •••• | Kadi, Gujarat, India |
| Ahmedabad Multichem Trade Solutions Private Limited | ₹3.86 Lakh (FY 2024) | •••• | •••• | -66.0% | •••• | Ahmedabad, Gujarat, India |
| Ita Chem Impex Private Limited | ₹3.8 Lakh (FY 2025) | •••• | •••• | -60.0% | •••• | Mumbai, Maharashtra, India |
| Capella Wellness Private Limited | ₹3.74 Lakh (FY 2025) | •••• | •••• | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Bequeath Pharmaceutical by revenue in the same principal business activity (Manufacture of chemicals and chemical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Bequeath Pharmaceutical Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Bequeath Pharmaceutical Private Limited
Bequeath Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bequeath Pharmaceutical Private Limited
Bequeath Pharmaceutical Private Limited has a workforce of 0 employees as of Apr 04, 2024.
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bequeath Pharmaceutical Private Limited
Bequeath Pharmaceutical Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Chandra Prakash ceased to be Director on 02 Aug 2025.
AGM
Bequeath Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Chandra Prakash ceased to be Director.
Appointed
Santosh Chaudhary was appointed as Director.
Filing
Bequeath Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Suman Kumari was appointed as Director.
Incorporation
29 Nov 2021
Bequeath Pharmaceutical Private Limited was registered on 29 Nov 2021 with Roc Delhi & aged 4 years 10 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Bequeath Pharmaceutical Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bequeath Pharmaceutical Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bequeath Pharmaceutical Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bequeath Pharmaceutical Private Limited
Bequeath Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAKCB3410E1ZI | Bihar | Active | 21 Sep 2022 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bequeath Pharmaceutical Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bequeath Pharmaceutical Private Limited
Bequeath Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 November 2021 (5+ years old) and is registered under CIN U24304DL2021PTC390572.
Bequeath Pharmaceutical reported revenue of ₹4.08 Lakh for FY 2025 (down 27% YoY).
Bequeath Pharmaceutical has 2 current directors:
- Suman Kumari - Director
- Santosh Chaudhary - Director
Bequeath Pharmaceutical reported a net profit of ₹54,173 (net margin 13.3%) and EBITDA of ₹54,173 (EBITDA margin 13.3%) for FY 2025, as per its filed financial statements.
The GSTIN of Bequeath Pharmaceutical is 10AAKCB3410E1ZI, registered in Bihar.
The CIN (Corporate Identification Number) of Bequeath Pharmaceutical is U24304DL2021PTC390572. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bequeath Pharmaceutical was incorporated on 29 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Bequeath Pharmaceutical by revenue are Reval Paints Private Limited, Medlong Life Sciences Private Limited, Ohc Innovations Private Limited, Twist Industries Private Limited, Gydan Life Science Private Limited and 5 more, all in the same principal business activity (Manufacture of chemicals and chemical products).
Chandra Prakash ceased to be Director on 02 Aug 2025. Santosh Chaudhary was appointed as Director on 29 Jul 2025. Suman Kumari was appointed as Director on 29 Nov 2021.
Yes, Bequeath Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0046203).
The registered office of Bequeath Pharmaceutical is at CO Surya Prakash 1179 – A GF Block – G – 1 Aya Nagar Extn Ph – 6, Delhi, India – 110047.